PROBE is a public-private partnership supported by the Innovative Health Initiative Joint Undertaking (IHI JU), set to impact the lives of OA patients across Europe. The consortium is led by the Erasmus University Medical Center (The Netherlands) as the Coordinator and Novartis Pharma AG (Switzerland) as the Project Lead.

IHI supports collaborative research projects and builds networks of industrial and academic experts in order to boost health research and innovation in Europe. This Joint Undertaking receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe, Vaccines Europe.